The first quarter results for the Medical Device sector showed slowing deal volume. A handful of big deals meant spending showed a slight gain.
After a booming January, February deal volume dies.
Allergan and Hologic each acquired companies targeting the medical aesthetic market, for a combined total of $4.4 billion.
The final month of the fourth quarter is typically a busy one for deal makers in all industries. Last year, some health care deal makers apparently got a rest. Deal volume in December 2016 was an anemic 119 transactions, compared with 131 deals in November and 148 in December 2015. The Services sectors accounted for […]
Deal volume in the Biotechnology sector is poised to surpass last year’s record-setting 160 transactions. With two weeks left in 2016, deal volume has reached 159 transactions. The activity in this sector shows no signs of abating, and will probably carry through the first half of 2017, at least.